A number of studies have shown the amazing weight loss potential of a new group of drugs, known to many by their brand names as Ozempic (which is for diabetes), Wegovy and Mounjaro. But how do these new drugs work? How were they discovered and who can use them? This is part of a new mini-series called the The Briefing Room Explainers. They’re short versions of previous episodes of the Briefing Room. Presenter: David Aaronovitch Producers: Charlotte McDonald, Kirsteen Knight and Beth Ashmead Latham Studio Manager: Neil Churchill Editor: Richard Vadon Production Co-ordinator: Gemma Ashman